Can Hormone Help Treat Multiple Sclerosis Long-Term?
March 10-2013
A new study suggests that treatment with
adrenocorticotropic hormone (ACTH) may be helpful for people whose multiple
sclerosis (MS) is not well-controlled through their regular treatment. The
study was released today and will be presented at the American Academy of
Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
Common MS Drugs
Common Multiple Sclerosis Drugs Taken Together Do Not Reduce Relapse Risk
March 11-2013
A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings published today in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
March 11-2013
A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings published today in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
Subscribe to:
Posts (Atom)